Abstract
Whole body FDG18 PET imaging has been shown to have 99% sensitivity in detecting primary tumor at initial workup for non-small cell lung cancer. Furthermore, it has been shown to have 91% sensitivity at detecting mediastinal lymph nodes pre-operatively. In this phase I/II study of neoadjuvant chemoradiotherapy followed by surgical resection for stage IIIA and IIIB non-small cell lung cancer patients, PET imaging was obtained before and after induction chemoradiotherapy in order to assess its ability to accurately assess pathologic response.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: International Journal of Radiation Oncology*Biology*Physics
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
